Monroe Capital announced the funding of a $46.5 million unitranche credit facility to support the recapitalization of Conisus, LLC by private equity sponsor, Webster Capital.

Based in Atlanta, GA, Conisus offers innovative, scientific-oriented promotional marketing and education solutions to a diverse group of biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies. The company is led by a seasoned management team with deep experience in oncology that spans medical education, global marketing, sales and clinical practice.

Monroe Capital is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada.

Founded in 2003, Webster Capital is a private equity partnership with over $200 million in capital under management which invests in healthcare services, branded consumer and business to business companies. Webster focuses on companies with EBITDA of between $3 million to $15 million and transaction values of less than $100 million. Webster Capital provides equity financing, expertise and a broad contact network for management buyouts and growth capital.